Is Left Ventricular Diastolic Dysfunction a clinical predictor of Syncope?

Size: px
Start display at page:

Download "Is Left Ventricular Diastolic Dysfunction a clinical predictor of Syncope?"

Transcription

1 Is Left Ventricular Diastolic Dysfunction a clinical predictor of Syncope? Abdul Jawwad Samdani, MBBS Mentor: Mrinalini Meesala, MD Yuji Saito, MD

2 What is Syncope? Why it is important? Common clinical problem Introduction % of all emergency room visits 1 6 % of hospital admissions annually in the US Incidence increasing with age Maybe disabling Trivial to Life threatening causes. Challenging differential diagnoses Extensive testing with enormous financial burden.

3 Introduction Causes Of Syncope Reflex/ Neurally- Mediated Orthostatic Cardiac Arrhythmia Structural Cardio- Pulmonary 1 Vasovagal Syncope Carotid sinus syndrome Situational Cough Post- Micturition 2 Drug-Induced Dehydration/ Hypovolemia ANS Failure Primary Secondary 3 Brady SN Dysfunction AV Block Tachy VT SVT Long QT Syndrome 4 Acute MI AS or MS HCM PulmHTN/ PE Aortic Dissection Cardiac tumor/ thrombus Unexplained Causes = Approximately 1/3 DG Benditt, MD. U of M Cardiac Arrhythmia Center

4 Introduction What is the utility of echocardiogram in evaluation of syncope? An echocardiogram has been described as an important tool with variable utility in the workup of syncope. Traditionally mainly used for identifying and quantifying an underlying structural heart disease (LVOT obstruction, valvular heart disease and cardiomyopathy).

5 Introduction Echocardiography can provide additional information for diagnostic and risk stratification purposes. Certain recent studies suggest that a small left atrial volume and lower mitral A velocity (a measure of atrial kick in LV filling) can predict positive Head up Tilt Test seen in neurocardiogenic syncope. Other studies suggest that LVDD may have a PARTIAL role in pathogenesis of syncope in patients with HOCM and Severe AS

6 Introduction No direct studies to date to evaluate possible role of LVDD in pathophysiology of syncope There is an overlap in risk factor associated with syncope and LVDD (Age, obesity, HTN, DM) Pathophysiologically, we know that LVDD results in a smaller stroke volume and hence a lower cardiac output that may facilitate causation of syncope.

7 Objectives To elucidate If Left Ventricular Diastolic Dysfunction (LVDD) is a clinical predictor of Syncope If Echocardiography plays a role in risk stratifying patients presenting with syncope in the absence of underlying structural heart disease.

8 METHODOLOGY

9 Methodology Retrospective Chart Review Single center: SOCH Duration: January 2011 to Dec 2012 Adult patients 18 years 2 groups; Syncope and Comparison group (Control) IRB Approval obtained No conflicts of interest or financial disclosures

10 Methodology: Sample Selection Echocardiography database searched by Syncope Echocardiography database searched by Routine Pre op and Evaluate Cardiac/ LV function N = 421 N = 463 Exclusion Diagnoses of Seizure, TIA, Fall, Presyncope Exclusion EF < 50% Severe Aortic (AS) and Mitral Valve disease HOCM AFib/ Flutter Acute coronary syndrome CHF exacerbation Limited Echo Exclusion Diagnosis of Syncope. Incomplete data Syncope Cases: N = 197 Control Group: N = 170

11 Methodology: Data Collection Performa Demographics Co morbids and medications 2 D Echocardiographic parameters Cause of syncope per discharge summary

12 Methodology: Data Collection Echocardiographic measurements and grading of LVDD per American Society of Echocardiography guidelines.

13

14

15 Methodology Statistical Analysis: SPSS version 20 Chi square 2 sample independent t test One way ANOVA p value of <0.05 considered significant

16 RESULTS

17 Results Demographics p = Cases Controls

18 Results Co morbids Cases Controls Percentages

19 Results Medications Drugs Syncope (n=197) Control (n=170) p value Beta Blockers % CCBs % Diuretics % ACEI/ARB % Nitrates % Hydralazine % Clonidine %

20 Results LVDD Frequency Percentages p< 0.001** p= 0.004** LVDD Grade 1 Grade 2 Grade 3 Cases Controls **P-value adjusted for Age, BMI, Gender, Race, HTN and DM

21 Results Other Cardiac Parameters Means 4 3 Syncope Control 2 p= p = E Velocity (m/s) A Velocity (m/s) E/A E' Velocity (m/s) E/E'

22 Results Other Cardiac Parameters Cardiac Parameters Syncope (n=197) Control (n=170) p value HR (Mean ± SD) 70.9 ± ± LVEF (Mean ± SD) 62.8 ± ± LVIDd (Mean ±SD) 4.5 ± ± LVM index (Mean ± SD) 87.8 ± ± LVH % LA size (Mean ±SD) 3.5 ± ± ** LA volume index (Mean ± SD) 24.3 ± ± E Velocity (Mean ± SD) 0.77 ± ± ** A (Mean ± SD) 0.84 ± ± E/A (Mean ± SD) 1.0 ± ± DT (Mean ± SD) ± ± IVRT (Mean ± SD) 88.7 ± ± E Velocity (Mean ± SD) 0.12 ± ± ** E/E (Mean ±SD) 6.8 ± ± LA pressure (Mean ± SD) 10.3 ± ±

23 Results Sub group Analysis Orthostatic 17% Causes of Syncope Cardiac 14% Undiagnosed 46% Reflex/Neural 23%

24 Subgroup Analysis LVDD Frequency Percentage p= p= LVDD Grade 1 Grade 2 Grade 3 Reflex/ Neural Cardiac Orthostatic

25 Comparison between Causes of Syncope p< p< p= p= p < Age (mean) HTN (%) DM (%) CAD (%) CHF (%) Reflex/ Neural Cardiac Orthostatic

26 Comparison between Causes of Syncope p= p= p = p< p= LVM index (gm/kg2) LVH (%) LA volume index cm3/ kg2 A (cm/s) E/E' Reflex/ Neural Cardiac Orthostatic

27 Results Comparison between Causes Variables of Interest Reflex Cardiac Orthostatic p value n=45 n=27 n=34 Age (Mean) <0.001 BMI (Mean) HTN % <0.003 DM % CAD % CHF % <0.001 LVEF (Mean) LVIDd (Mean) LVM index (Mean) LVH % LA size (Mean) <0.001 LA volume index (Mean) <0.001 E Velocity (Mean) A Velocity (Mean) E/A (Mean) DT (Mean) IVRT (Mean) E Velocity (Mean) LA pressure (Mean) RVSP (Mean) LVDD % Normal % Grade 1 % Grade 2 % Grade 3 % 0 4 0

28 Conclusion Our results show that LVDD is more common in patients with syncope than the control group reaching statistical significance Hence LVDD is likely a predictor of syncope. Also, presence of LVH, larger LAV index, higher mitral A velocity, larger E/E and presence of LVDD are significant predictors of cardiac syncope in the absence of structural heart disease

29 Implications/ Future Considerations Hypothesis generation for future studies to explore the link between LVDD and Syncope Echocardiography may have additional role in the evaluation of syncope. Parameters like LVH, LAVI, A velocity and LVDD can likely be incorporated in the risk stratification tools/ score systems in evaluation of syncope and can be further studied.

30 Limitations Retrospective design Causal association can not be definitely established Hospital based data lacking generalizability

31 References 1. Manganelli F, Betocchi S, Ciampi Q, Storto G, Losi MA, Violante A, et al. Comparison of hemodynamic adaptation to orthostatic stress in patients with hypertrophic cardiomyopathy with or without syncope and in vasovagal syncope. Am J Cardiol 2002;89(12): Folino AF, Russo G, Buja G, Iliceto S. Contribution of decreased atrial function in the pathogenesis of neurally mediated syncope. Am J Cardiol 2006;97(7): Sarasin FP, Junod AF, Carballo D, Slama S, Unger PF, Louis Simonet M. Role of echocardiography in the evaluation of syncope: a prospective study. Heart 2002;88(4): Moon J, Shim J, Park JH, Hwang HJ, Joung B, Ha JW, et al. Small left atrial volume is an independent predictor for fainting during head up tilt test: the impact of intracardiac volume reserve in vasovagal syncope. Int J Cardiol 2013;166(1): Park SJ, Enriquez Sarano M, Chang SA, Choi JO, Lee SC, Park SW, et al. Hemodynamic patterns for symptomatic presentations of severe aortic stenosis. JACC Cardiovasc Imaging 2013;6(2): Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr Feb;22(2): doi: /j.echo Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr Dec;18(12): Puppala VK, Dickinson O, Benditt DG. Syncope: classification and risk stratification. J Cardiol Mar;63(3): doi: /j.jjcc Epub 2014 Jan Puppala VK, Dickinson O, Benditt DG. Syncope: classification and risk stratification. J Cardiol Mar;63(3): doi: /j.jjcc Epub 2014 Jan Thiruganasambandamoorthy V, Stiell IG, Sivilotti ML, Murray H, Rowe BH, Lang E, McRae A, Sheldon R, Wells GA. Risk stratification of adult emergency department syncope patients to predict short term serious outcomes after discharge (RiSEDS) study. BMC Emerg Med Mar 14;14:8. doi: / X 14 8.

32 Thank you Questions?

33 Supplementary Slides

34 Results Demographics Syncope (n=197) Control (n=170) p value Age (Mean ±SD) 66.5 ± ± Gender Male % Female % Race Caucasians % African Americans % Other % BMI (Mean ±SD) 27.8 ± ± **

35 Results Comorbids Syncope (n=197) Control (n=170) p value HTN % DM % CAD % CHF % CVA % Paroxysmal Afib % COPD/ Asthma % DL % Active Tobacco % CKD % Previous Syncope %

36 RESULTS SUBGROUP ANALYSIS CAUSE of SYNCOPE Unknown n (%) 91 (46.2) Reflex/ Neural n (%) 45 (22.8) Cardiac n (%) 27 (13.7) Orhtstatic n (%) 34 (17.3)

37 RESULTS LVDD Frequency Syncope (n=197) Control (n=170) p value LVDD % ** Adjusted*** <0.001** Grade 1 % Grade 2 % ** Grade 3 % Adjusted*** 0.004** *** Adjusted for Age, Gender, Race, HTN, DM and BMI

38 Results Comparison between Causes Unknown Reflex Cardiac Orthostatic p value Age (Mean) <0.001** HTN % <0.001** DM % ** CAD % ** CHF % <0.001** LVEF (Mean) LVIDd (Mean) LVM index (Mean) ** LVH % ** LA size (Mean) <0.001** LA volume index (Mean) <0.001** E Velocity (Mean) A (Mean) ** E/A (Mean) DT (Mean) IVRT (Mean) E Velocity (Mean) E/E (Mean) LA pressure (Mean) LVDD % ** Grade 1 % Grade 2 % ** Grade 3 %

39 Methodology: Sample Selection Echocardiography database searched by Syncope N = 421 Echocardiography database searched by Routine Pre op and Evaluate Cardiac/ LV function N = 463 Exclusion Diagnoses of Seizure, TIA, Fall, Presyncope Exclusion EF < 50% Severe Aortic (AS) and Mitral Valve disease HOCM AFib/ Flutter Acute coronary syndrome CHF exacerbation Limited Echo Incomplete data Exclusion EF < 50% Severe Aortic (AS) and Mitral Valve disease HOCM AFib/ Flutter Acute coronary syndrome CHF exacerbation Limited Echo Incomplete data Exclusion Diagnosis of Syncope. Syncope Cases: N = 197 Control Group: N = 170

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation

More information

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic

More information

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469)

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469) Provider Checklist-Outpatient Imaging Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code 78451-78454 78469) Medical Review Note: Per InterQual, if any of the following are present,

More information

Atrial Fibrillation The Basics

Atrial Fibrillation The Basics Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation

More information

Professor Rose Anne Kenny, St James Hospital &Trinity College, Dublin

Professor Rose Anne Kenny, St James Hospital &Trinity College, Dublin Syncope Presentation and Investigation in the Acute Setting Professor Rose Anne Kenny, St James Hospital &Trinity College, Dublin Definition- Presentation Syncope is a syndrome consisting of a relatively

More information

38 year old female with mild obesity. She is planning an exercise program to loose weight. She has no other known risk factors for CAD.

38 year old female with mild obesity. She is planning an exercise program to loose weight. She has no other known risk factors for CAD. Stress Testing: Wael A. Jaber, MD,FACC 38 year old female with mild obesity She is planning an exercise program to loose weight. She has no other known risk factors for CAD. You recommend: A. Exercise

More information

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation. DISCLOSURES I have no relevant financial relationships to disclose. Cardiac Evaluation of Potential Solid Organ Transplant Recipients Michele Hamilton, MD Director, Heart Failure Program Cedars Sinai Heart

More information

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI

Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Atrial Fibrillation and Cardiac Device Therapy RAKESH LATCHAMSETTY, MD DIVISION OF ELECTROPHYSIOLOGY UNIVERSITY OF MICHIGAN HOSPITAL ANN ARBOR, MI Outline Atrial Fibrillation What is it? What are the associated

More information

Atrial Fibrillation Management Across the Spectrum of Illness

Atrial Fibrillation Management Across the Spectrum of Illness Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,

More information

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains

More information

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia

More information

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015

Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015 Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.

More information

Non Invasive Testing for CAD

Non Invasive Testing for CAD Non Invasive Testing for CAD Wael A. Jaber, MD Section of Cardiac Imaging Heart and Vascular Institute Cleveland Clinic 38 year old female with mild obesity She is planning an exercise program to loose

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

How do you decide on rate versus rhythm control?

How do you decide on rate versus rhythm control? Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study

More information

Atrial Fibrillation An update on diagnosis and management

Atrial Fibrillation An update on diagnosis and management Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.

More information

CTA OF THE EXTRACORONARY HEART

CTA OF THE EXTRACORONARY HEART CTA OF THE EXTRACORONARY HEART Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland NO DISCLOSURES [email protected] CARDIAC CASE DISTRIBUTION Coronary CTA 30% ED chest

More information

Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout.

Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout. Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout. TLoC is common huge variation in management range of clinicians

More information

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity Jean-Luc MONIN, MD, PhD Henri Mondor University Hospital Créteil, FRANCE Disclosures : None 77-year-old woman, mild dyspnea

More information

Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier

Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier Episode 20 Atrial fibrillation Prepared by Dr. Lucas Chartier Most common dysrhythmia seen in ED, and incidence increasing with ageing population Presentation Common presentations: younger patients often

More information

Cardiac Syncope. spot it, stop it! Syncope is Tranient Loss of Consciousness (T- LOC) due to: transient global cerebral hypoperfusion

Cardiac Syncope. spot it, stop it! Syncope is Tranient Loss of Consciousness (T- LOC) due to: transient global cerebral hypoperfusion Definition Cardiac Syncope spot it, stop it! David Gareth Jones Heart Rhythm Centre Royal Brompton & Harefield NHS Foundation Trust Syncope is Tranient Loss of Consciousness (T- LOC) due to: transient

More information

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)

HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs) HTEC 91 Medical Office Diagnostic Tests Week 4 Topic for Today: Atrial Rhythms PACs: Premature Atrial Contractions PAT: Paroxysmal Atrial Tachycardia AF: Atrial Fibrillation Atrial Flutter Premature Atrial

More information

TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours)

TABLE 1 Clinical Classification of AF. New onset AF (first detected) Paroxysmal (<7 days, mostly < 24 hours) Clinical Practice Guidelines for the Management of Patients With Atrial Fibrillation Deborah Ritchie RN, MN, Robert S Sheldon MD, PhD Cardiovascular Research Group, University of Calgary, Alberta Partly

More information

Il loop recorder esterno. Roberto Maggi

Il loop recorder esterno. Roberto Maggi Il loop recorder esterno Roberto Maggi ECG monitoring and syncope In-hospital monitoring Holter Monitoring Event recorder External loop recorder Remote (at home) telemetry Implantable loop recorder External

More information

Atrial Fibrillation Peter Santucci, MD Revised May, 2008

Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is

More information

Managing the Patient with Atrial Fibrillation

Managing the Patient with Atrial Fibrillation Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION

More information

Syncope 2015: Evaluation and Treatment. Steve Greer, MD FHRS BHHI Primary Care Symposium February 27, 2015

Syncope 2015: Evaluation and Treatment. Steve Greer, MD FHRS BHHI Primary Care Symposium February 27, 2015 Syncope 2015: Evaluation and Treatment Steve Greer, MD FHRS BHHI Primary Care Symposium February 27, 2015 Financial disclosures Research Support National Heart, Lung, and Blood Institute Boston Scientific

More information

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology

Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Cardiology ICD-10-CM Coding Tip Sheet Overview of Key Chapter Updates for Cardiology Chapter 4: Endocrine, Nutritional, and Metabolic Diseases (E00-E89) The diabetes mellitus codes are combination codes

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Nursing Care and Considerations for Patients with Atrial Fibrillation. Kris Kinghorn RN, MSN, ANP-BC

Nursing Care and Considerations for Patients with Atrial Fibrillation. Kris Kinghorn RN, MSN, ANP-BC Nursing Care and Considerations for Patients with Atrial Fibrillation Kris Kinghorn RN, MSN, ANP-BC Case Study 66 y/o female (Mrs. Olus A. Blader) Admitted with c/o palpitations and lightheadedness PMH:

More information

Clinical Glidepath TM Tools Syncope Frail Life expectancy less than five years or significant functional impairment

Clinical Glidepath TM Tools Syncope Frail Life expectancy less than five years or significant functional impairment Robust Elderly greater ALL GROUPS 1 SYMPTOMS a) wth, nausea b) postural symptoms c) chest pain, dyspnea, post-exercise, dizziness, history of heart disease, palpitations, family history (prolonged QT)

More information

Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015

Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015 Atrial Fibrillation: Do We Have A Cure? Raymond Kawasaki, MD AMG Electrophysiology February 21, 2015 Disclaimer I have no relationships to disclose Do we have a cure for Atrial Fibrillation? The short

More information

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty

CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary

More information

Ngaire has Palpitations

Ngaire has Palpitations Ngaire has Palpitations David Heaven Cardiac Electrophysiologist/Heart Rhythm Specialist Middlemore, Auckland City and Mercy Hospitals Auckland Heart Group MCQ Ms A is 45, and a healthy marathon runner.

More information

The debate: Should all AF patients see an EP consultant?

The debate: Should all AF patients see an EP consultant? The debate: Should all AF patients see an EP consultant? Pre-debate show of hands in favour of the motion The argument for the motion: Dr Nick Kelland The argument against the motion: Dr Andy McCoye Discussion

More information

Fellow TEE Review Workshop Hemodynamic Calculations 2013. Director, Intraoperative TEE Program. Johns Hopkins School of Medicine

Fellow TEE Review Workshop Hemodynamic Calculations 2013. Director, Intraoperative TEE Program. Johns Hopkins School of Medicine Fellow TEE Review Workshop Hemodynamic Calculations 2013 Mary Beth Brady, MD, FASE Director, Intraoperative TEE Program Johns Hopkins School of Medicine At the conclusion of the workshop, the participants

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

A 35 yo female presents increasing fatigue and shortness of breath for several days. She is found to be in atrial fibrillation.

A 35 yo female presents increasing fatigue and shortness of breath for several days. She is found to be in atrial fibrillation. Ryan G. Aleong Cardiology Department University of Colorado A 35 yo female presents increasing fatigue and shortness of breath for several days. She is found to be in atrial fibrillation. 1. Initiation

More information

Syncope. Approach Diagnosis and Treatment. Robert Satran MD

Syncope. Approach Diagnosis and Treatment. Robert Satran MD Syncope Approach Diagnosis and Treatment Robert Satran MD Transient Loss of Consciousness (TLOC) Transient Loss of Consciousness (TLOC ) Classification Underlying Mechanism Is Transient Global Cerebral

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

Efficient Evaluation of Chest Pain

Efficient Evaluation of Chest Pain Efficient Evaluation of Chest Pain Vikranth Gongidi, DO FACC FACOI Indian River Medical Center Vero Beach, FL No Disclosures Outline Background Chest pain pathway Indications for stress test Stress test

More information

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long

More information

Anticoagulation Therapy Update

Anticoagulation Therapy Update Anticoagulation Therapy Update JUDY R. WALLING, FNP-BC ARRHYTHMIA MANAGEMENT MUSC CARDIOLOGY Outline Who do we anticoagulate? Review classes of Anticoagulants Review examples of Anticoagulants Review CHADS2

More information

Electrocardiographic Issues in Williams Syndrome

Electrocardiographic Issues in Williams Syndrome Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital

More information

Inconsistencies in the Use of Cardiac Biomarkers or Echocardiography in Patients with Acute Non-Massive Pulmonary Embolism

Inconsistencies in the Use of Cardiac Biomarkers or Echocardiography in Patients with Acute Non-Massive Pulmonary Embolism Inconsistencies in the Use of Cardiac Biomarkers or Echocardiography in Patients with Acute Non-Massive Pulmonary Embolism The Swiss Venous Thromboembolism Registry (SWIVTER) Nils Kucher University Hospital

More information

Diana Heiman, MD Associate Professor, Family Medicine Residency Director East Tennessee State University

Diana Heiman, MD Associate Professor, Family Medicine Residency Director East Tennessee State University Diana Heiman, MD Associate Professor, Family Medicine Residency Director East Tennessee State University Objectives Define exercise associated collapse (EAC) and exercise-associated postural hypotension

More information

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery Srinivasan Rajagopal M.D. Assistant Professor Division of Cardiothoracic Anesthesia Objectives Describe the pathophysiology

More information

Presenter Disclosure Information

Presenter Disclosure Information 2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.

More information

Does Depression affect compliance with CPAP therapy in patients with Obstructive Sleep Apnea? Ramesh Metta, MBBS M Jeffery Mador, MD

Does Depression affect compliance with CPAP therapy in patients with Obstructive Sleep Apnea? Ramesh Metta, MBBS M Jeffery Mador, MD Does Depression affect compliance with CPAP therapy in patients with Obstructive Sleep Apnea? Ramesh Metta, MBBS M Jeffery Mador, MD Background Obstructive Sleep Apnea(OSA) Obstructive sleep apnea (OSA)

More information

PRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia

PRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia PRACTICAL APPROACH TO SVT Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia CONDUCTION SYSTEM OF THE HEART SA node His bundle Left bundle AV node Right

More information

5/1/2015. When should I worry? Presyncope is the feeling that one is about to pass out but remains conscious with a transient loss of postural tone.

5/1/2015. When should I worry? Presyncope is the feeling that one is about to pass out but remains conscious with a transient loss of postural tone. When should I worry? Robert Vogt-Lowell, MD, FAAP, FAAC, MAAC Pediatric Cardiologist Pediatrix Cardiology of Miami DEFINITIONS Syncope is a transient loss of consciousness and muscle tone that results

More information

R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney,

R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney, R.P. Zecchin*, J. Baihn, Y.Y. Chai, J. Hungerford, G. Lindsay, M. Owen, J. Thelander, D.L. Ross, C. Chow, A.R. Denniss. Westmead Hospital, Sydney, Australia Cardiac rehabilitation is an effective and safe

More information

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular Mitral Regurgitation Anatomy Mechanisms of MR Presentation Evaluation Management Repair Replace Clip

More information

on behalf of the AUGMENT-HF Investigators

on behalf of the AUGMENT-HF Investigators One Year Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure* Douglas

More information

James F. Kravec, M.D., F.A.C.P

James F. Kravec, M.D., F.A.C.P James F. Kravec, M.D., F.A.C.P Chairman, Department of Internal Medicine, St. Elizabeth Health Center Chair, General Internal Medicine, Northeast Ohio Medical University Associate Medical Director, Hospice

More information

Vs. K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, M. Savvopoulou, E. Avramidou, D. Vassilopoulou, V. Voudris

Vs. K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, M. Savvopoulou, E. Avramidou, D. Vassilopoulou, V. Voudris Vs. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, M.

More information

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis Michael A. Blazing Outline The coming crush A practical approach to clinical risk assessment Classic approach to

More information

2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them?

2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? 2014: nowadays the one shot technologies and the injectable monitor allow a wide and complete AF patient management. Why shouldn t we use them? Gaetano Senatore DIVISION OF CARDIOLOGY HOSPITAL OF CIRIE

More information

Normal ranges of left ventricular global longitudinal strain: A meta-analysis of 2484 subjects

Normal ranges of left ventricular global longitudinal strain: A meta-analysis of 2484 subjects Normal ranges of left ventricular global longitudinal strain: A meta-analysis of 2484 subjects Teerapat Yingchoncharoen MD. Shikar Agarwal MD. MPH. Thomas H. Marwick MBBS. Ph.D. MPH. Cleveland Clinic Foundation

More information

Autonomic Stress Test

Autonomic Stress Test Autonomic Stress Test (The expanded head-up tilt test) Artur Fedorowski Syncope Unit Skåne University Hospital, Malmö, Sweden NordSync 2011, Malmö Disclosure None The expanded head-up tilt test When? Why?

More information

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL

Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL Marilyn Borkgren-Okonek, APN, CCNS, RN, MS Suburban Lung Associates, S.C. Elk Grove Village, IL www.goldcopd.com GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE GLOBAL STRATEGY FOR DIAGNOSIS, MANAGEMENT

More information

INHERIT. The Lancet Diabetes & Endocrinology In press

INHERIT. The Lancet Diabetes & Endocrinology In press INHibition of the renin angiotensin system in hypertrophic cardiomyopathy and the Effect on hypertrophy a Randomized Intervention Trial with losartan Anna Axelsson, Kasper Iversen, Niels Vejlstrup, Carolyn

More information

Conflicts of interest: None

Conflicts of interest: None Syncope in Athletes Thomas G. Allison, PhD, MPH Mayo Clinic Rochester, MN USA 13 th Annual Review Course in Clinical Cardiology Zurich 14 April, 2015 CP972908-1 Conflicts of interest: None Syncope: Definition

More information

The new Heart Failure pathway

The new Heart Failure pathway The new Heart Failure pathway An integrated and seamless Strategy Dr Sunil Balani Definition of Heart Failure The inability of the heart to pump blood at a rate commensurate with the requirements of metabolising

More information

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY

ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF

More information

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY Charles Jazra NO CONFLICT OF INTEREST TO DECLARE Relationship Between Atrial Fibrillation and Age Prevalence, percent

More information

Objectives. The ECG in Pulmonary and Congenital Heart Disease. Lead II P-Wave Amplitude during COPD Exacerbation and after Treatment (50 pts.

Objectives. The ECG in Pulmonary and Congenital Heart Disease. Lead II P-Wave Amplitude during COPD Exacerbation and after Treatment (50 pts. The ECG in Pulmonary and Congenital Heart Disease Gabriel Gregoratos, MD Objectives Review the pathophysiology and ECG signs of pulmonary dysfunction Review the ECG findings in patients with: COPD (chronic

More information

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications

More information

Table 1 Performance Measures. Quality Monitoring P4P Yr1 Yr2 Yr3. Specification Source. # Category Performance Measure

Table 1 Performance Measures. Quality Monitoring P4P Yr1 Yr2 Yr3. Specification Source. # Category Performance Measure Table 1 Performance Measures # Category Performance Measure 1 Behavioral Health Risk Assessment and Follow-up 1) Behavioral Screening/ Assessment within 60 days of enrollment New Enrollees who completed

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

Potential Causes of Sudden Cardiac Arrest in Children

Potential Causes of Sudden Cardiac Arrest in Children Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are

More information

Chest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd.

Chest Pain in Young Athletes. Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego cdavis@rchsd. Chest Pain in Young Athletes Christopher Davis, MD, PhD Pediatric Cardiology Rady Children s Hospital San Diego [email protected] 858-966-5855 None Disclosures Chest Pain: the good news and the bad news:

More information

Disclosure. All the authors have no conflict of interest to disclose in this study.

Disclosure. All the authors have no conflict of interest to disclose in this study. Assessment of Left Atrial Deformation and Dyssynchrony by Three-dimensional Speckle Tracking Imaging: Comparative Studies in Healthy Subjects and Patients with Atrial Fibrillation Atsushi Mochizuki, MD*;

More information

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Heart Failure Center Hadassah University Hospital Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease Israel Gotsman MD The Heart Failure Center, Heart Institute Hadassah University

More information

Donor Adverse Events

Donor Adverse Events Donor Adverse Events Common terminology Frequency Risk factors Hold still, Mrs. Brown, while I draw your blood Mindy Goldman, MD Canadian Blood Services IHN Seminar, Paris March 11, 2016 Outline Donor

More information

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA

1p36 and the Heart. John Lynn Jefferies, MD, MPH, FACC, FAHA 1p36 and the Heart John Lynn Jefferies, MD, MPH, FACC, FAHA Director, Advanced Heart Failure and Cardiomyopathy Services Associate Professor, Pediatric Cardiology and Adult Cardiovascular Diseases Associate

More information

Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014

Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014 Anticoagulation: How Do I Pick From All the Choices? Jeffrey H. Neuhauser, DO, FACC BHHI Primary Care Symposium February 28, 2014 Atrial Fibrillation 2 Atrial Fibrillation The most common arrhythmia encountered

More information

TILT TESTING INFORMATION AND PROTOCOLS

TILT TESTING INFORMATION AND PROTOCOLS TILT TESTING INFORMATION AND PROTOCOLS For technicians and doctors June 2008 Dr Nicola Cooper Consultant in Acute Medicine & Geriatrics TILT TESTING This information has been compiled for technicians and

More information

Approach to the Patient with Syncope

Approach to the Patient with Syncope Syncope Case Study 38-year-old female with recurrent syncope occasionally occurring during emotional stressful times. Her physical examination and 12 lead EKG are normal. Approach to the Patient with Syncope

More information

Management of Pacing Wires After Cardiac Surgery

Management of Pacing Wires After Cardiac Surgery Management of Pacing Wires After Cardiac Surgery David E. Lizotte, Jr. PA C, MPAS, FAPACVS President, Association of Physician Assistants in Cardiovascular Surgery Conflicts: None Indications 2008 Journal

More information

Normal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent.

Normal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent. Normal Sinus Rhythm (NSR) Rate: 60-100 per minute Rhythm: R- R = P waves: Upright, similar P-R: 0.12-0.20 second & consistent P:qRs: 1P:1qRs Sinus Tachycardia Exercise Hypovolemia Medications Fever Hypoxia

More information

Syncope in the Elderly Assessment and Treatment. Professor Rose Anne Kenny Trinity College Dublin Newcastle University

Syncope in the Elderly Assessment and Treatment. Professor Rose Anne Kenny Trinity College Dublin Newcastle University Syncope in the Elderly Assessment and Treatment Professor Rose Anne Kenny Trinity College Dublin Newcastle University Definition Syncope is a syndrome consisting of a relatively short period of temporary

More information

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital

Atrial Fibrillation: A Different Perspective. Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Atrial Fibrillation: A Different Perspective Michael Heffernan MD PhD FRCPC FACC Staff Cardiologist Oakville Hospital Faculty/Presenter Disclosure Faculty: Dr. Michael Heffernan Relationships with commercial

More information

The author has no disclosures

The author has no disclosures Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 [email protected] This presentation will discuss unlabeled and investigational use of products The author

More information

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years

Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957

More information

SYNCOPE a symptom, not a diagnosis

SYNCOPE a symptom, not a diagnosis SYNCOPE a symptom, not a diagnosis Dr Jaycen Cruickshank Ballarat Emergency Education Grampians Emergency Medicine Training Hub Syncope Learning objectives Learning objectives To name the common and important

More information